Clinical Trial Update: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effectiveness of low molecular weight sulfated dextran in islet transplantation for type 1 diabetes. Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Low Molecular Weight Sulfated Dextran (low molecular weight sulfated dextran)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type I | Phase 2 | Status: COMPLETED